Market & News

Amrutanjan Health Care Limited has set September 11, 2026, as the record date for the payment of a final dividend for the financial year 2025-26, according to a filing with the National Stock Exchange of India Limited and BSE Limited.

A disclosure document dated August 11, 2026, reveals that promoters and related entities of a company hold a significant number of shares, totaling approximately 83.34 million, but none are currently pledged. Key entities, including Satyadharma Investments and Trading Company Private Ltd, Castle Investment & Industries Private Limited, and Lyon Investment & Industries Private Limited, hold substantial portions of the total shares, ranging from 19.1% to 15.0%. The document details a complex ownership structure involving numerous private limited companies, trusts, and individual promoters, and serves as a transparency measure for regulatory bodies or lenders. The total share count used for percentage calculations is assumed to be 83,34,280, and the disclosure does not indicate any current risk associated with pledged shares.

Bliss GVS Pharma Limited announced that its ESOP Allotment Committee approved the allotment of 31,250 equity shares to eligible employees under the Bliss GVS Pharma Limited – Employee Stock Option Plan 2019, increasing the company’s issued, subscribed, and paid-up share capital from 10,62,43,973 equity shares aggregating Rs 10,62,43,973 to 10,62,75,222 equity shares aggregating Rs 10,62,75,222.

Reliance Infrastructure Limited will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results for both standalone and consolidated entities for the quarter ended June 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited.

Finolex Cables Limited announced the re-appointment of Vanessa Singh, Zubin Billimoria, and Sriraman Raghuraman as Independent Directors, and Ratnakar Barve as a Whole-time Director, for a second term of five years, subject to shareholder approval. The appointments, effective September 30, 2026, were approved at a board meeting held on August 11, 2026, and detailed disclosures are included in an annexure filed with the Bombay Stock Exchange and National Stock Exchange of India.

JSW Dulux Limited, formerly Akzo Nobel India Limited, announced on Tuesday, August 11, 2026, that its board approved a sub-division/split of its existing equity shares, converting one share with a face value of Rs 10 into 10 shares with a face value of Rs 1 each. The company also approved alterations to its Memorandum and Articles of Association to reflect the share split, which will increase the number of equity shares from 4,55,40,314 to 45,54,03,140. The move aims to enhance affordability and accessibility for retail investors, subject to shareholder approval via postal ballot and any required regulatory approvals.

Walchandnagar Industries Limited reported no deviation or variation in the use of proceeds raised through a preferential issue of Rs 247.59 crore, according to a filing with the National Stock Exchange of India Ltd and BSE Ltd on August 11, 2026. The company had previously raised Rs 216.00 crore from investors and adjusted Rs 31.59 crore towards the conversion/appropriation of an outstanding loan.

Tamilnadu Petroproducts Limited announced that its board of directors approved the company’s unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and convened its 41st Annual General Meeting scheduled for September 25, 2026, at 2:00 PM (IST) via video conferencing or other audio-visual mode. The board also recommended a dividend of Rs 1.50 per equity share of Rs 10 each and appointed Sanket Balvantrao Waghe, IAS (DIN: 11865401), as an Additional Director under the Non-Executive Non-Independent category, effective August 11, 2026, and appointed M/s. B Y & Associates, Cost Accountants, Chennai as the Cost Auditors for the financial year 2026-27.

Shah Foods Limited will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review reports from its statutory auditors, as required under Regulation 33(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; the trading window for the company's securities has been closed since July 1, 2026, and will remain closed until 48 hours after the financial results are declared to the stock exchanges.

Mangal Credit and Fincorp Limited will hold a board meeting on Friday, August 14, 2026, to consider a proposal for fund raising through the issuance of Non-Convertible Debentures, subject to requisite approvals.